Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1974-07-24
1977-05-17
Padgett, Benjamin R.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
2523011R, 252316, A61K 2900, A61K 4300
Patent
active
040242331
ABSTRACT:
A reagent comprising macroaggregated human serum albumin having dispersed therein particles of stannous tin and a method for instantly making a labeled pharmaceutical therefrom, are disclosed. The labeled pharmaceutical is utilized in organ imaging.
REFERENCES:
patent: 3663685 (1972-05-01), Evans
patent: 3663687 (1972-05-01), Evans
patent: 3725295 (1973-04-01), Eckelmann et al.
patent: 3803299 (1974-04-01), Novel
patent: 3863004 (1975-01-01), Wolfangel
patent: 3872226 (1975-03-01), Haney et al.
Benjamin, International Journal Applied Radiation and Isotopes, vol. 20, 1969, pp. 187-194.
Honda et al., Journal of Nuclear Medicine, vol. 11, No. 10, 1970, pp. 580-585.
Morcellet et al., Journal de Biologie et de Nucleairos, vol. 4, No. 17, May-June, 1969, pp. 16-18.
Berger et al., Isotopenpraxis, vol. 7, 1971, pp. 188-189.
Eckelman et al., Radiology, vol. 102, Jan. 1972, pp. 185-186.
Robbins et al., Journal of Nuclear Medicine, vol. 13, No. 6, 1972.
Barak Morton
Van Fleet, III Parmer
Winchell Harry S.
Leon Bernard S.
Medi--Physics, Inc.
Nucker Christine M.
Padgett Benjamin R.
Swope R. Hain
LandOfFree
99M-technetium labeled macroaggregated human serum albumin pharm does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 99M-technetium labeled macroaggregated human serum albumin pharm, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 99M-technetium labeled macroaggregated human serum albumin pharm will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1834872